NCT01367574View on ClinicalTrials.gov

Methylnaltrexone in Patients With Opioid-Induced Bowel Dysfunction

PHASE2CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

April 30, 2002

Primary Completion Date

May 31, 2003

Study Completion Date

May 31, 2003

Conditions
Bowel Dysfunction
Interventions
DRUG

SC MNTX

Dose 1

DRUG

SC MNTX

Dose 2

DRUG

SC MNTX

Dose 3

Trial Locations (1)

10591

Progenics Pharmaceuticals, Inc., Tarrytown

All Listed Sponsors
lead

Bausch Health Americas, Inc.

INDUSTRY

NCT01367574 - Methylnaltrexone in Patients With Opioid-Induced Bowel Dysfunction | Biotech Hunter | Biotech Hunter